Discover 1,922 paid clinical trials in Irving, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,922
Active & Responsive
Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
for
Graves' Disease
Location: Fort Worth TX, Conroe TX, Houston TX, Humble TX,
Sponsor: Yarrow Bioscience, Inc.
Sex: All
Age: 18+
Code: NCT07682896
Phase2, Recruiting
Active & ResponsiveNew
An Open-Label, Safety and Efficacy Study of Cebranopadol in Participants With Acute Pain With Surgical or Non-Surgical Origin
Active Music-Based Intervention in Patients With Chronic Low Back Pain
for
Chronic Low Back Pain
Location: Denton TX
Sponsor: Sharon Wang-Price
Sex: All
Age: 18 - 65
Code: NCT06940063
Recruiting
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
for
Graves' Disease
Location: Irving TX, Dallas TX, Fort Worth TX, McKinney TX,
Sponsor: Immunovant Sciences GmbH
Sex: All
Age: 18 - 70+
Code: NCT07018323
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants
for
Systemic Lupus Erythematosus (SLE) or Cutaneous Lupus Erythematosus,
Location: Irving TX, San Antonio TX, Clearwater FL, Orlando FL,
Sponsor: DualityBio Inc.
Sex: All
Age: 18 - 70
Code: NCT06625671
Phase1, Phase2, Recruiting
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
for
Refractory Rheumatoid Arthritis (RA),
Location: Irving TX, Arlington TX, Mesquite TX, Red Oak TX,
Sponsor: Artiva Biotherapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06991114
Phase2, Recruiting
Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs
for
Failed or Difficult Intubation, Sequela, Intubation; Difficult,
Location: Irving TX, Dallas TX, Austin TX, San Antonio TX,
Sponsor: Children's Hospital of Philadelphia
Sex: All
Age: 0+
Code: NCT02493478
Recruiting
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
for
Prostate Cancer
Location: Irving TX, Houston TX, Merriam KS, St Louis MO,
Sponsor: Amgen
Sex: Male
Age: 18+
Code: NCT04221542
Phase1, Recruiting
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
for
Metastatic HER2-positive Breast Cancer
Location: Irving TX, Fort Worth TX, Houston TX, Kansas City MO,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06435429
Phase3, Recruiting
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
for
Breast Cancer
Location: Irving TX, Lewisville TX, Flower Mound TX, Allen TX,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07062965
Phase3, Recruiting
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Location: Irving TX, Waco TX, Austin TX, The Woodlands TX,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07421700
Phase1, Phase2, Recruiting
Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
for
Metastatic Castration Sensitive Prostate Cancer (mCSPC),
Location: Irving TX, Dallas TX, Richardson TX, Fort Worth TX,
Sponsor: Pfizer
Sex: Male
Age: 18+
Code: NCT07028853
Phase3, Recruiting
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
for
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic,
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
for
Colorectal Neoplasms
Location: Irving TX, Dallas TX, Houston TX, Pueblo CO,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All
Age: 18+
Code: NCT05253651
Phase3, Recruiting
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)